{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:19:21Z","timestamp":1792300761242,"version":"4.4.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T00:00:00Z","timestamp":1587600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T00:00:00Z","timestamp":1587600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s10096-020-03897-6","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T10:03:43Z","timestamp":1594202623000},"page":"1209-1220","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening"],"prefix":"10.1007","volume":"39","author":[{"given":"Xiaoxuan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuepeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,23]]},"reference":[{"key":"3897_CR1","unstructured":"Organization. WH (2005) Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)"},{"issue":"5","key":"3897_CR2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/aji.12243","volume":"71","author":"JY Kwon","year":"2014","unstructured":"Kwon JY, Romero R, Mor G (2014) New insights into the relationship between viral infection and pregnancy complications. Am J Reprod Immunol 71(5):387\u2013390","journal-title":"Am J Reprod Immunol"},{"issue":"6648","key":"3897_CR3","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/bmj.297.6648.584","volume":"297","author":"ME Price","year":"1988","unstructured":"Price ME, Fisher-Hoch SP, Craven RB, McCormick JB (1988) A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. BMJ 297(6648):584\u2013587","journal-title":"BMJ"},{"issue":"5","key":"3897_CR4","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/AOG.0000000000000533","volume":"124","author":"DJ Jamieson","year":"2014","unstructured":"Jamieson DJ, Uyeki TM, Callaghan WM, Meaney-Delman D, Rasmussen SA (2014) What obstetrician-gynecologists should know about Ebola: a perspective from the Centers for Disease Control and Prevention. Obstet Gynecol 124(5):1005\u20131010","journal-title":"Obstet Gynecol"},{"issue":"3","key":"3897_CR5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1471-0528.2008.02027.x","volume":"116","author":"NM Fisk","year":"2009","unstructured":"Fisk NM, Atun R (2009) Systematic analysis of research underfunding in maternal and perinatal health. BJOG 116(3):347\u2013356","journal-title":"BJOG"},{"issue":"1","key":"3897_CR6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ccm.2016.11.007","volume":"38","author":"DS Hui","year":"2017","unstructured":"Hui DS (2017) Epidemic and emerging coronaviruses (severe acute respiratory syndrome and Middle East respiratory syndrome). Clin Chest Med 38(1):71\u201386","journal-title":"Clin Chest Med"},{"key":"3897_CR7","doi-asserted-by":"crossref","unstructured":"Song Z, Xu Y, Bao L, Zhang L, Yu P, Qu Y, Zhu H, Zhao W, Han Y, Qin C (2019) From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses 11(1)","DOI":"10.3390\/v11010059"},{"issue":"3","key":"3897_CR8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","volume":"17","author":"J Cui","year":"2019","unstructured":"Cui J, Li F, Shi ZL (2019) Origin and evolution of pathogenic coronaviruses. NAT REV MICROBIOL 17(3):181\u2013192","journal-title":"NAT REV MICROBIOL"},{"key":"3897_CR9","first-page":"1","volume":"287","author":"DA Brian","year":"2005","unstructured":"Brian DA, Baric RS (2005) Coronavirus genome structure and replication. Curr Top Microbiol Immunol 287:1\u201330","journal-title":"Curr Top Microbiol Immunol"},{"key":"3897_CR10","doi-asserted-by":"crossref","unstructured":"Zhou Y, Jiang S, Du L (2018) Prospects for a MERS-CoV spike vaccine. Expert Rev Vaccines 17(8):677\u2013686","DOI":"10.1080\/14760584.2018.1506702"},{"issue":"6","key":"3897_CR11","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","volume":"24","author":"S Su","year":"2016","unstructured":"Su S, Wong G, Shi W, Liu J, Lai A, Zhou J, Liu W, Bi Y, Gao GF (2016) Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 24(6):490\u2013502","journal-title":"Trends Microbiol"},{"issue":"10224","key":"3897_CR12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y, Ma X, Zhan F, Wang L, Hu T, Zhou H, Hu Z, Zhou W, Zhao L, Chen J, Meng Y, Wang J, Lin Y, Yuan J, Xie Z, Ma J, Liu WJ, Wang D, Xu W, Holmes EC, Gao GF, Wu G, Chen W, Shi W, Tan W (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. LANCET 395(10224):565\u2013574","journal-title":"LANCET"},{"key":"3897_CR13","doi-asserted-by":"crossref","unstructured":"Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS (2020) Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367(6483):1260\u20131263","DOI":"10.1126\/science.abb2507"},{"key":"3897_CR14","doi-asserted-by":"crossref","unstructured":"Yan R, Zhang Y, Guo Y, Xia L, Zhou Q (2020) Structural basis for the recognition of the 2019-nCoV by human ACE2. bioRxiv:2020\u20132022","DOI":"10.1101\/2020.02.19.956946"},{"key":"3897_CR15","doi-asserted-by":"crossref","unstructured":"Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, Zhang Q, Shi X, Wang Q, Zhang L, Wang X (2020) Crystal structure of the 2019-nCoV spike receptor-binding domain bound with the ACE2 receptor. bioRxiv:2020\u20132022","DOI":"10.1101\/2020.02.19.956235"},{"key":"3897_CR16","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/jama.1961.03040220024005","volume":"176","author":"TC EICKHOFF","year":"1961","unstructured":"EICKHOFF TC, SHERMAN IL, SERFLING RE (1961) Observations on excess mortality associated with epidemic influenza. JAMA 176:776\u2013782","journal-title":"JAMA"},{"issue":"4","key":"3897_CR17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/AOG.0b013e3181d57947","volume":"115","author":"AA Creanga","year":"2010","unstructured":"Creanga AA, Johnson TF, Graitcer SB, Hartman LK, Al-Samarrai T, Schwarz AG, Chu SY, Sackoff JE, Jamieson DJ, Fine AD, Shapiro-Mendoza CK, Jones LE, Uyeki TM, Balter S, Bish CL, Finelli L, Honein MA (2010) Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women. Obstet Gynecol 115(4):717\u2013726","journal-title":"Obstet Gynecol"},{"issue":"12","key":"3897_CR18","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/bja\/42.12.1100","volume":"42","author":"GF Marx","year":"1970","unstructured":"Marx GF, Murthy PK, Orkin LR (1970) Static compliance before and after vaginal delivery. Br J Anaesth 42(12):1100\u20131104","journal-title":"Br J Anaesth"},{"issue":"2","key":"3897_CR19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1152\/jappl.1992.73.2.393","volume":"73","author":"DA Bayliss","year":"1992","unstructured":"Bayliss DA, Millhorn DE (1992,) Central neural mechanisms of progesterone action: application to the respiratory system. J Appl Physiol 73(2):393\u2013404","journal-title":"J Appl Physiol"},{"key":"3897_CR20","doi-asserted-by":"crossref","unstructured":"Field SK, Bell SG, Cenaiko DF, Whitelaw WA (1991) Relationship between inspiratory effort and breathlessness in pregnancy. J Appl Physiol (1985) 71 (5):1897\u20131902","DOI":"10.1152\/jappl.1991.71.5.1897"},{"issue":"7","key":"3897_CR21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1017\/S0022215100092902","volume":"96","author":"H Toppozada","year":"1982","unstructured":"Toppozada H, Michaels L, Toppozada M, El-Ghazzawi I, Talaat M, Elwany S (1982) The human respiratory nasal mucosa in pregnancy. An electron microscopic and histochemical study. J Laryngol Otol 96(7):613\u2013626","journal-title":"J Laryngol Otol"},{"issue":"7 Pt 1","key":"3897_CR22","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1097\/00005537-199907000-00018","volume":"109","author":"M Bende","year":"1999","unstructured":"Bende M, Gredmark T (1999) Nasal stuffiness during pregnancy. LARYNGOSCOPE 109(7 Pt 1):1108\u20131110","journal-title":"LARYNGOSCOPE"},{"issue":"23","key":"3897_CR23","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMra1213566","volume":"370","author":"AP Kourtis","year":"2014","unstructured":"Kourtis AP, Read JS, Jamieson DJ (2014) Pregnancy and infection. N Engl J Med 370(23):2211\u20132218","journal-title":"N Engl J Med"},{"issue":"12","key":"3897_CR24","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s12471-011-0219-9","volume":"19","author":"PG Pieper","year":"2011","unstructured":"Pieper PG, Hoendermis ES (2011) Pregnancy in women with pulmonary hypertension. NETH HEART J 19(12):504\u2013508","journal-title":"NETH HEART J"},{"issue":"3 Suppl","key":"3897_CR25","first-page":"58s","volume":"62","author":"DM Nelson","year":"1983","unstructured":"Nelson DM, Main E, Crafford W, Ahumada GG (1983) Peripartum heart failure due to primary pulmonary hypertension. OBSTET GYNECOL 62(3 Suppl):58s\u201363s","journal-title":"OBSTET GYNECOL"},{"issue":"6","key":"3897_CR26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1600-0897.2010.00836.x","volume":"63","author":"G Mor","year":"2010","unstructured":"Mor G, Cardenas I (2010) The immune system in pregnancy: a unique complexity. Am J Reprod Immunol 63(6):425\u2013433","journal-title":"Am J Reprod Immunol"},{"issue":"3","key":"3897_CR27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/aji.12355","volume":"73","author":"M Silasi","year":"2015","unstructured":"Silasi M, Cardenas I, Kwon JY, Racicot K, Aldo P, Mor G (2015) Viral infections during pregnancy. Am J Reprod Immunol 73(3):199\u2013213","journal-title":"Am J Reprod Immunol"},{"key":"3897_CR28","first-page":"416739","volume":"2012","author":"L Sykes","year":"2012","unstructured":"Sykes L, MacIntyre DA, Yap XJ, Ponnampalam S, Teoh TG, Bennett PR (2012) Changes in the Th1:Th2 cytokine bias in pregnancy and the effects of the anti-inflammatory cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J2. Mediat Inflamm 2012:416739","journal-title":"Mediat Inflamm"},{"issue":"5","key":"3897_CR29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jsbmb.2005.08.010","volume":"97","author":"R Druckmann","year":"2005","unstructured":"Druckmann R, Druckmann MA (2005) Progesterone and the immunology of pregnancy. J Steroid Biochem Mol Biol 97(5):389\u2013396","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"3897_CR30","doi-asserted-by":"crossref","first-page":"e1006173","DOI":"10.1371\/journal.ppat.1006173","volume":"13","author":"G Muallem","year":"2017","unstructured":"Muallem G, Wagage S, Sun Y, DeLong JH, Valenzuela A, Christian DA, Harms PG, Fang Q, Buza EL, Jain D, Elloso MM, Lopez CB, Hunter CA (2017) IL-27 limits type 2 immunopathology following parainfluenza virus infection. PLoS Pathog 13(1):e1006173","journal-title":"PLoS Pathog"},{"issue":"7","key":"3897_CR31","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.medcli.2016.03.019","volume":"147","author":"A Danza","year":"2016","unstructured":"Danza A, Ruiz-Irastorza G, Khamashta M (2016) Pregnancy in systemic autoimmune diseases: myths, certainties and doubts. Med Clin (Barc) 147(7):306\u2013312","journal-title":"Med Clin (Barc)"},{"issue":"1\u20133","key":"3897_CR32","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s12026-012-8303-9","volume":"54","author":"M Pazos","year":"2012","unstructured":"Pazos M, Sperling RS, Moran TM, Kraus TA (2012) The influence of pregnancy on systemic immunity. Immunol Res 54(1\u20133):254\u2013261","journal-title":"Immunol Res"},{"issue":"2","key":"3897_CR33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2567.2006.02559.x","volume":"121","author":"AL Zoller","year":"2007","unstructured":"Zoller AL, Schnell FJ, Kersh GJ (2007) Murine pregnancy leads to reduced proliferation of maternal thymocytes and decreased thymic emigration. IMMUNOLOGY 121(2):207\u2013215","journal-title":"IMMUNOLOGY"},{"issue":"2","key":"3897_CR34","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s10875-011-9627-2","volume":"32","author":"TA Kraus","year":"2012","unstructured":"Kraus TA, Engel SM, Sperling RS, Kellerman L, Lo Y, Wallenstein S, Escribese MM, Garrido JL, Singh T, Loubeau M, Moran TM (2012) Characterizing the pregnancy immune phenotype: results of the viral immunity and pregnancy (VIP) study. J Clin Immunol 32(2):300\u2013311","journal-title":"J Clin Immunol"},{"issue":"1","key":"3897_CR35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2042-6410-1-5","volume":"1","author":"SL Klein","year":"2010","unstructured":"Klein SL, Passaretti C, Anker M, Olukoya P, Pekosz A (2010) The impact of sex, gender and pregnancy on 2009 H1N1 disease. Biol Sex Differ 1(1):5","journal-title":"Biol Sex Differ"},{"issue":"15","key":"3897_CR36","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1001\/jama.2010.479","volume":"303","author":"AM Siston","year":"2010","unstructured":"Siston AM, Rasmussen SA, Honein MA, Fry AM, Seib K, Callaghan WM, Louie J, Doyle TJ, Crockett M, Lynfield R, Moore Z, Wiedeman C, Anand M, Tabony L, Nielsen CF, Waller K, Page S, Thompson JM, Avery C, Springs CB, Jones T, Williams JL, Newsome K, Finelli L, Jamieson DJ (2010) Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA 303(15):1517\u20131525","journal-title":"JAMA"},{"issue":"1\u20132","key":"3897_CR37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.imlet.2010.06.003","volume":"132","author":"M Pierdominici","year":"2010","unstructured":"Pierdominici M, Maselli A, Colasanti T, Giammarioli AM, Delunardo F, Vacirca D, Sanchez M, Giovannetti A, Malorni W, Ortona E (2010) Estrogen receptor profiles in human peripheral blood lymphocytes. Immunol Lett 132(1\u20132):79\u201385","journal-title":"Immunol Lett"},{"key":"3897_CR38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12948-016-0048-x","volume":"14","author":"MP Piccinni","year":"2016","unstructured":"Piccinni MP, Lombardelli L, Logiodice F, Kullolli O, Parronchi P, Romagnani S (2016) How pregnancy can affect autoimmune diseases progression? Clin Mol Allergy 14:11","journal-title":"Clin Mol Allergy"},{"issue":"8","key":"3897_CR39","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3899\/jrheum.140583","volume":"42","author":"B Bharti","year":"2015","unstructured":"Bharti B, Lee SJ, Lindsay SP, Wingard DL, Jones KL, Lemus H, Chambers CD (2015) Disease severity and pregnancy outcomes in women with rheumatoid arthritis: results from the Organization of Teratology Information Specialists Autoimmune Diseases in pregnancy project. J Rheumatol 42(8):1376\u20131382","journal-title":"J Rheumatol"},{"issue":"4","key":"3897_CR40","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0165-6147(00)01994-5","volume":"23","author":"AJ Turner","year":"2002","unstructured":"Turner AJ, Hooper NM (2002) The angiotensin-converting enzyme gene family: genomics and pharmacology. Trends Pharmacol Sci 23(4):177\u2013183","journal-title":"Trends Pharmacol Sci"},{"issue":"5","key":"3897_CR41","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","volume":"87","author":"M Donoghue","year":"2000","unstructured":"Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S (2000) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87(5):E1\u2013E9","journal-title":"Circ Res"},{"issue":"14","key":"3897_CR42","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1161\/01.CIR.0000094734.67990.99","volume":"108","author":"LS Zisman","year":"2003","unstructured":"Zisman LS, Keller RS, Weaver B, Lin Q, Speth R, Bristow MR, Canver CC (2003) Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme homologue ACE2. CIRCULATION 108(14):1707\u20131712","journal-title":"CIRCULATION"},{"issue":"17","key":"3897_CR43","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1161\/01.CIR.0000092888.63239.54","volume":"108","author":"DB Averill","year":"2003","unstructured":"Averill DB, Ishiyama Y, Chappell MC, Ferrario CM (2003) Cardiac angiotensin-(1-7) in ischemic cardiomyopathy. CIRCULATION 108(17):2141\u20132146","journal-title":"CIRCULATION"},{"key":"3897_CR44","doi-asserted-by":"crossref","unstructured":"Hoffmann M, Kleine-Weber H, Kr\u00fcger N, M\u00fcller M, Drosten C, P\u00f6hlmann S (2020) The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv:2020\u20132021","DOI":"10.1101\/2020.01.31.929042"},{"issue":"7","key":"3897_CR45","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.burns.2015.04.010","volume":"41","author":"Z Yilin","year":"2015","unstructured":"Yilin Z, Yandong N, Faguang J (2015) Role of angiotensin-converting enzyme (ACE) and ACE2 in a rat model of smoke inhalation induced acute respiratory distress syndrome. BURNS 41(7):1468\u20131477","journal-title":"BURNS"},{"issue":"8","key":"3897_CR46","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1590\/S0100-879X2004000800017","volume":"37","author":"KB Brosnihan","year":"2004","unstructured":"Brosnihan KB, Neves LA, Anton L, Joyner J, Valdes G, Merrill DC (2004) Enhanced expression of Ang-(1-7) during pregnancy. Braz J Med Biol Res 37(8):1255\u20131262","journal-title":"Braz J Med Biol Res"},{"issue":"1","key":"3897_CR47","doi-asserted-by":"crossref","first-page":"R169","DOI":"10.1152\/ajpregu.00387.2006","volume":"293","author":"J Joyner","year":"2007","unstructured":"Joyner J, Neves LA, Granger JP, Alexander BT, Merrill DC, Chappell MC, Ferrario CM, Davis WP, Brosnihan KB (2007) Temporal-spatial expression of ANG-(1-7) and angiotensin-converting enzyme 2 in the kidney of normal and hypertensive pregnant rats. Am J Physiol Regul Integr Comp Physiol 293(1):R169\u2013R177","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"6","key":"3897_CR48","doi-asserted-by":"crossref","first-page":"R1953","DOI":"10.1152\/ajpregu.90592.2008","volume":"295","author":"A Levy","year":"2008","unstructured":"Levy A, Yagil Y, Bursztyn M, Barkalifa R, Scharf S, Yagil C (2008) ACE2 expression and activity are enhanced during pregnancy. Am J Physiol Regul Integr Comp Physiol 295(6):R1953\u2013R1961","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"3897_CR49","doi-asserted-by":"crossref","unstructured":"Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, Li J, Zhao D, Xu D, Gong Q, Liao J, Yang H, Hou W, Zhang Y (2020) Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet","DOI":"10.1016\/S0140-6736(20)30360-3"},{"issue":"5","key":"3897_CR50","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1067\/mob.2000.108888","volume":"183","author":"JK Davies","year":"2000","unstructured":"Davies JK, Shikes RH, Sze CI, Leslie KK, McDuffie RJ, Romero R, Gibbs RS (2000) Histologic inflammation in the maternal and fetal compartments in a rabbit model of acute intra-amniotic infection. Am J Obstet Gynecol 183(5):1088\u20131093","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"3897_CR51","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1002\/eji.200737744","volume":"37","author":"B Salaun","year":"2007","unstructured":"Salaun B, Romero P, Lebecque S (2007) Toll-like receptors\u2019 two-edged sword: when immunity meets apoptosis. Eur J Immunol 37(12):3311\u20133318","journal-title":"Eur J Immunol"},{"issue":"1","key":"3897_CR52","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-0897.2009.00791.x","volume":"63","author":"SA Madsen-Bouterse","year":"2010","unstructured":"Madsen-Bouterse SA, Romero R, Tarca AL, Kusanovic JP, Espinoza J, Kim CJ, Kim J, Edwin SS, Gomez R, Draghici S (2010) ORIGINAL ARTICLE: the transcriptome of the fetal inflammatory response syndrome. Am J Reprod Immunol 63(1):73\u201392","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"3897_CR53","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuron.2009.09.002","volume":"64","author":"BE Deverman","year":"2009","unstructured":"Deverman BE, Patterson PH (2009) Cytokines and CNS development. NEURON 64(1):61\u201378","journal-title":"NEURON"},{"issue":"1","key":"3897_CR54","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbi.2008.07.012","volume":"23","author":"L Shi","year":"2009","unstructured":"Shi L, Smith SE, Malkova N, Tse D, Su Y, Patterson PH (2009) Activation of the maternal immune system alters cerebellar development in the offspring. Brain Behav Immun 23(1):116\u2013123","journal-title":"Brain Behav Immun"},{"issue":"40","key":"3897_CR55","doi-asserted-by":"crossref","first-page":"10695","DOI":"10.1523\/JNEUROSCI.2178-07.2007","volume":"27","author":"SE Smith","year":"2007","unstructured":"Smith SE, Li J, Garbett K, Mirnics K, Patterson PH (2007) Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 27(40):10695\u201310702","journal-title":"J Neurosci"},{"issue":"3","key":"3897_CR56","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.drudis.2019.01.018","volume":"24","author":"CC Li","year":"2019","unstructured":"Li CC, Wang XJ, Wang HR (2019) Repurposing host-based therapeutics to control coronavirus and influenza virus. Drug Discov Today 24(3):726\u2013736","journal-title":"Drug Discov Today"},{"issue":"7","key":"3897_CR57","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/bdra.20682","volume":"88","author":"SS Roberts","year":"2010","unstructured":"Roberts SS, Miller RK, Jones JK, Lindsay KL, Greene MF, Maddrey WC, Williams IT, Liu J, Spiegel RJ (2010) The ribavirin pregnancy registry: findings after 5 years of enrollment, 2003-2009. Birth Defects Res A Clin Mol Teratol 88(7):551\u2013559","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"Suppl 4","key":"3897_CR58","first-page":"1","volume":"15","author":"A de Ruiter","year":"2014","unstructured":"de Ruiter A, Taylor GP, Clayden P, Dhar J, Gandhi K, Gilleece Y, Harding K, Hay P, Kennedy J, Low-Beer N, Lyall H, Palfreeman A, O'Shea S, Tookey P, Tosswill J, Welch S, Wilkins E (2014) British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review). HIV MED 15(Suppl 4):1\u201377","journal-title":"HIV MED"},{"issue":"6","key":"3897_CR59","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/QCO.0000000000000017","volume":"26","author":"A Colbers","year":"2013","unstructured":"Colbers A, Greupink R, Burger D (2013) Pharmacological considerations on the use of antiretrovirals in pregnancy. Curr Opin Infect Dis 26(6):575\u2013588","journal-title":"Curr Opin Infect Dis"},{"issue":"8","key":"3897_CR60","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s40261-018-0656-y","volume":"38","author":"D Plantone","year":"2018","unstructured":"Plantone D, Koudriavtseva T (2018) Current and future use of chloroquine and hydroxychloroquine in infectious, immune, neoplastic, and neurological diseases: a mini-review. CLIN DRUG INVEST 38(8):653\u2013671","journal-title":"CLIN DRUG INVEST"},{"issue":"8","key":"3897_CR61","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1128\/AAC.01509-08","volume":"53","author":"E Keyaerts","year":"2009","unstructured":"Keyaerts E, Li S, Vijgen L, Rysman E, Verbeeck J, Van Ranst M, Maes P (2009) Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice. Antimicrob Agents Chemother 53(8):3416\u20133421","journal-title":"Antimicrob Agents Chemother"},{"key":"3897_CR62","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","volume":"2","author":"MJ Vincent","year":"2005","unstructured":"Vincent MJ, Bergeron E, Benjannet S, Erickson BR, Rollin PE, Ksiazek TG, Seidah NG, Nichol ST (2005) Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J 2:69","journal-title":"Virol J"},{"issue":"1","key":"3897_CR63","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbrc.2004.08.085","volume":"323","author":"E Keyaerts","year":"2004","unstructured":"Keyaerts E, Vijgen L, Maes P, Neyts J, Van Ranst M (2004) In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine. Biochem Biophys Res Commun 323(1):264\u2013268","journal-title":"Biochem Biophys Res Commun"},{"issue":"6965","key":"3897_CR64","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"W Li","year":"2003","unstructured":"Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. NATURE 426(6965):450\u2013454","journal-title":"NATURE"},{"key":"3897_CR65","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jaut.2016.06.016","volume":"74","author":"MG Lazzaroni","year":"2016","unstructured":"Lazzaroni MG, Dall'Ara F, Fredi M, Nalli C, Reggia R, Lojacono A, Ramazzotto F, Zatti S, Andreoli L, Tincani A (2016) A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus. J Autoimmun 74:106\u2013117","journal-title":"J Autoimmun"},{"issue":"6","key":"3897_CR66","doi-asserted-by":"crossref","first-page":"766","DOI":"10.6061\/clinics\/2013(06)07","volume":"68","author":"JC Silva","year":"2013","unstructured":"Silva JC, Mariz HA, Rocha LJ, Oliveira PS, Dantas AT, Duarte AL, Pitta IR, Galdino SL, Pitta MG (2013) Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients. Clinics (Sao Paulo) 68(6):766\u2013771","journal-title":"Clinics (Sao Paulo)"},{"key":"3897_CR67","doi-asserted-by":"crossref","unstructured":"Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G (2020) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30(3):269\u2013271","DOI":"10.1038\/s41422-020-0282-0"},{"key":"3897_CR68","doi-asserted-by":"crossref","unstructured":"Klumpp TG (1965) Safety of chloroquine in pregnancy. JAMA 191 (9):765","DOI":"10.1001\/jama.1965.03080090079027"},{"issue":"5","key":"3897_CR69","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/bcp.12872","volume":"81","author":"YC Kaplan","year":"2016","unstructured":"Kaplan YC, Ozsarfati J, Nickel C, Koren G (2016) Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: a systematic review and meta-analysis. Br J Clin Pharmacol 81(5):835\u2013848","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"3897_CR70","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1371\/journal.pmed.0030343","volume":"3","author":"LJ Stockman","year":"2006","unstructured":"Stockman LJ, Bellamy R, Garner P (2006) SARS: systematic review of treatment effects. PLoS Med 3(9):e343","journal-title":"PLoS Med"},{"issue":"3","key":"3897_CR71","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nm1001","volume":"10","author":"BL Haagmans","year":"2004","unstructured":"Haagmans BL, Kuiken T, Martina BE, Fouchier RA, Rimmelzwaan GF, van Amerongen G, van Riel D, de Jong T, Itamura S, Chan KH, Tashiro M, Osterhaus AD (2004) Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat Med 10(3):290\u2013293","journal-title":"Nat Med"},{"issue":"24","key":"3897_CR72","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1001\/jama.290.24.3222","volume":"290","author":"MR Loutfy","year":"2003","unstructured":"Loutfy MR, Blatt LM, Siminovitch KA, Ward S, Wolff B, Lho H, Pham DH, Deif H, LaMere EA, Chang M, Kain KC, Farcas GA, Ferguson P, Latchford M, Levy G, Dennis JW, Lai EK, Fish EN (2003) Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. JAMA 290(24):3222\u20133228","journal-title":"JAMA"},{"issue":"9390","key":"3897_CR73","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(03)14484-4","volume":"362","author":"H Moriguchi","year":"2003","unstructured":"Moriguchi H, Sato C (2003) Treatment of SARS with human interferons. LANCET 362(9390):1159","journal-title":"LANCET"},{"issue":"7","key":"3897_CR74","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/jac\/dkv085","volume":"70","author":"S Shalhoub","year":"2015","unstructured":"Shalhoub S, Farahat F, Al-Jiffri A, Simhairi R, Shamma O, Siddiqi N, Mushtaq A (2015) IFN-alpha2a or IFN-beta1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study. J Antimicrob Chemother 70(7):2129\u20132132","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"3897_CR75","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.reprotox.2011.11.003","volume":"33","author":"BP Yazdani","year":"2012","unstructured":"Yazdani BP, Matok I, Garcia BF, Koren G (2012) A systematic review of the fetal safety of interferon alpha. Reprod Toxicol 33(3):265\u2013268","journal-title":"Reprod Toxicol"},{"issue":"7","key":"3897_CR76","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1177\/135965350701200711","volume":"12","author":"M van der Lee","year":"2007","unstructured":"van der Lee M, Sankatsing R, Schippers E, Vogel M, Fatkenheuer G, van der Ven A, Kroon F, Rockstroh J, Wyen C, Baumer A, de Groot E, Koopmans P, Stroes E, Reiss P, Burger D (2007) Pharmacokinetics and pharmacodynamics of combined use of lopinavir\/ritonavir and rosuvastatin in HIV-infected patients. Antivir Ther 12(7):1127\u20131132","journal-title":"Antivir Ther"},{"issue":"3","key":"3897_CR77","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/thorax.2003.012658","volume":"59","author":"CM Chu","year":"2004","unstructured":"Chu CM, Cheng VC, Hung IF, Wong MM, Chan KH, Chan KS, Kao RY, Poon LL, Wong CL, Guan Y, Peiris JS, Yuen KY (2004) Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings. THORAX 59(3):252\u2013256","journal-title":"THORAX"},{"key":"3897_CR78","unstructured":"Lin S, Shen R, Guo X (2020) Molecular modeling evaluation of the binding abilities of ritonavir and lopinavir to Wuhan pneumonia coronavirus proteases. bioRxiv:2020\u20132021"},{"issue":"2","key":"3897_CR79","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/QAI.0000000000000281","volume":"67","author":"CA Koss","year":"2014","unstructured":"Koss CA, Natureeba P, Plenty A, Luwedde F, Mwesigwa J, Ades V, Charlebois ED, Clark TD, Achan J, Ruel T, Nzarubara B, Kamya MR, Havlir DV, Cohan D (2014) Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir\/ritonavir- or efavirenz-based antiretroviral therapy. J Acquir Immune Defic Syndr 67(2):128\u2013135","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"3897_CR80","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/QAI.0b013e3181a2813f","volume":"51","author":"SS Roberts","year":"2009","unstructured":"Roberts SS, Martinez M, Covington DL, Rode RA, Pasley MV, Woodward WC (2009) Lopinavir\/ritonavir in pregnancy. J Acquir Immune Defic Syndr 51(4):456\u2013461","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"3897_CR81","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd.2017.162","volume":"17","author":"S Kaufmann","year":"2018","unstructured":"Kaufmann S, Dorhoi A, Hotchkiss RS, Bartenschlager R (2018) Host-directed therapies for bacterial and viral infections. Nat Rev Drug Discov 17(1):35\u201356","journal-title":"Nat Rev Drug Discov"},{"issue":"10223","key":"3897_CR82","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. LANCET 395(10223):497\u2013506","journal-title":"LANCET"},{"issue":"10224","key":"3897_CR83","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/S0140-6736(20)30305-6","volume":"395","author":"A Zumla","year":"2020","unstructured":"Zumla A, Hui DS, Azhar EI, Memish ZA, Maeurer M (2020) Reducing mortality from 2019-nCoV: host-directed therapies should be an option. LANCET 395(10224):e35\u2013e36","journal-title":"LANCET"},{"issue":"5","key":"3897_CR84","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","volume":"15","author":"A Zumla","year":"2016","unstructured":"Zumla A, Chan JF, Azhar EI, Hui DS, Yuen KY (2016) Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Discov 15(5):327\u2013347","journal-title":"Nat Rev Drug Discov"},{"key":"3897_CR85","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.antiviral.2019.04.006","volume":"167","author":"JH Beigel","year":"2019","unstructured":"Beigel JH, Nam HH, Adams PL, Krafft A, Ince WL, El-Kamary SS, Sims AC (2019) Advances in respiratory virus therapeutics - a meeting report from the 6th isirv antiviral group conference. Antivir Res 167:45\u201367","journal-title":"Antivir Res"},{"issue":"2","key":"3897_CR86","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1164\/rccm.200710-1602OC","volume":"178","author":"JW Zmijewski","year":"2008","unstructured":"Zmijewski JW, Lorne E, Zhao X, Tsuruta Y, Sha Y, Liu G, Siegal GP, Abraham E (2008) Mitochondrial respiratory complex I regulates neutrophil activation and severity of lung injury. Am J Respir Crit Care Med 178(2):168\u2013179","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"3897_CR87","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.fertnstert.2006.02.098","volume":"86","author":"C Gilbert","year":"2006","unstructured":"Gilbert C, Valois M, Koren G (2006) Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil Steril 86(3):658\u2013663","journal-title":"Fertil Steril"},{"issue":"1","key":"3897_CR88","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00404-014-3566-0","volume":"292","author":"G Li","year":"2015","unstructured":"Li G, Zhao S, Cui S, Li L, Xu Y, Li Y (2015) Effect comparison of metformin with insulin treatment for gestational diabetes: a meta-analysis based on RCTs. Arch Gynecol Obstet 292(1):111\u2013120","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"3897_CR89","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.antiviral.2013.06.018","volume":"99","author":"DS Fedson","year":"2013","unstructured":"Fedson DS (2013) Treating influenza with statins and other immunomodulatory agents. Antivir Res 99(3):417\u2013435","journal-title":"Antivir Res"},{"issue":"11","key":"3897_CR90","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/bdra.20181","volume":"73","author":"PS Pollack","year":"2005","unstructured":"Pollack PS, Shields KE, Burnett DM, Osborne MJ, Cunningham ML, Stepanavage ME (2005) Pregnancy outcomes after maternal exposure to simvastatin and lovastatin. Birth Defects Res A Clin Mol Teratol 73(11):888\u2013896","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"3897_CR91","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijid.2015.09.005","volume":"40","author":"A Zumla","year":"2015","unstructured":"Zumla A, Azhar EI, Arabi Y, Alotaibi B, Rao M, McCloskey B, Petersen E, Maeurer M (2015) Host-directed therapies for improving poor treatment outcomes associated with the middle east respiratory syndrome coronavirus infections. Int J Infect Dis 40:71\u201374","journal-title":"Int J Infect Dis"},{"key":"3897_CR92","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12906-016-1079-z","volume":"16","author":"DA Kennedy","year":"2016","unstructured":"Kennedy DA, Lupattelli A, Koren G, Nordeng H (2016) Safety classification of herbal medicines used in pregnancy in a multinational study. BMC Complement Altern Med 16:102","journal-title":"BMC Complement Altern Med"},{"issue":"6","key":"3897_CR93","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ptr.2362","volume":"22","author":"MN Asl","year":"2008","unstructured":"Asl MN, Hosseinzadeh H (2008) Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res 22(6):709\u2013724","journal-title":"Phytother Res"},{"issue":"9371","key":"3897_CR94","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0140-6736(03)13412-5","volume":"361","author":"JS Peiris","year":"2003","unstructured":"Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, Law KI, Tang BS, Hon TY, Chan CS, Chan KH, Ng JS, Zheng BJ, Ng WL, Lai RW, Guan Y, Yuen KY (2003) Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. LANCET 361(9371):1767\u20131772","journal-title":"LANCET"},{"issue":"7","key":"3897_CR95","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1572-0241.2000.02194.x","volume":"95","author":"JL Goldstein","year":"2000","unstructured":"Goldstein JL, Silverstein FE, Agrawal NM, Hubbard RC, Kaiser J, Maurath CJ, Verburg KM, Geis GS (2000) Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor. Am J Gastroenterol 95(7):1681\u20131690","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"3897_CR96","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/aje\/kwf130","volume":"156","author":"TE Strandberg","year":"2002","unstructured":"Strandberg TE, Andersson S, Jarvenpaa AL, McKeigue PM (2002) Preterm birth and licorice consumption during pregnancy. Am J Epidemiol 156(9):803\u2013805","journal-title":"Am J Epidemiol"},{"issue":"9","key":"3897_CR97","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/aje\/kwp272","volume":"170","author":"K Raikkonen","year":"2009","unstructured":"Raikkonen K, Pesonen AK, Heinonen K, Lahti J, Komsi N, Eriksson JG, Seckl JR, Jarvenpaa AL, Strandberg TE (2009) Maternal licorice consumption and detrimental cognitive and psychiatric outcomes in children. Am J Epidemiol 170(9):1137\u20131146","journal-title":"Am J Epidemiol"},{"issue":"2","key":"3897_CR98","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-0032-1328102","volume":"79","author":"JS Choi","year":"2013","unstructured":"Choi JS, Han JY, Ahn HK, Ryu HM, Kim MY, Chung JH, Nava-Ocampo AA, Koren G (2013) Fetal and neonatal outcomes in women reporting ingestion of licorice (Glycyrrhiza uralensis) during pregnancy. Planta Med 79(2):97\u2013101","journal-title":"Planta Med"},{"issue":"5\u20136","key":"3897_CR99","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000320956","volume":"86","author":"HY Li","year":"2010","unstructured":"Li HY, Xu W, Su J, Zhang X, Hu LW, Zhang WD (2010) In vitro and in vivo inhibitory effects of glycyrrhetinic acid on cytochrome P450 3A activity. PHARMACOLOGY 86(5\u20136):287\u2013292","journal-title":"PHARMACOLOGY"},{"issue":"2","key":"3897_CR100","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/IJN.S596","volume":"3","author":"WH De Jong","year":"2008","unstructured":"De Jong WH, Borm PJ (2008) Drug delivery and nanoparticles:applications and hazards. Int J Nanomedicine 3(2):133\u2013149","journal-title":"Int J Nanomedicine"},{"key":"3897_CR101","doi-asserted-by":"crossref","unstructured":"Caster JM, Patel AN, Zhang T, Wang A (2017) Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials. Wiley Interdiscip Rev Nanomed Nanobiotechnol 9(1)","DOI":"10.1002\/wnan.1416"},{"issue":"4","key":"3897_CR102","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/nrd3426","volume":"10","author":"A Flemming","year":"2011","unstructured":"Flemming A (2011) Vaccines: nano-adjuvant: double TLR stimulation is the key. Nat Rev Drug Discov 10(4):258","journal-title":"Nat Rev Drug Discov"},{"issue":"14","key":"3897_CR103","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2217\/nnm.15.48","volume":"10","author":"JA Keelan","year":"2015","unstructured":"Keelan JA, Leong JW, Ho D, Iyer KS (2015) Therapeutic and safety considerations of nanoparticle-mediated drug delivery in pregnancy. Nanomedicine (Lond) 10(14):2229\u20132247","journal-title":"Nanomedicine (Lond)"},{"issue":"3","key":"3897_CR104","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1289\/ehp.0901200","volume":"118","author":"P Wick","year":"2010","unstructured":"Wick P, Malek A, Manser P, Meili D, Maeder-Althaus X, Diener L, Diener PA, Zisch A, Krug HF, von Mandach U (2010) Barrier capacity of human placenta for nanosized materials. Environ Health Perspect 118(3):432\u2013436","journal-title":"Environ Health Perspect"},{"issue":"3","key":"3897_CR105","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jconrel.2010.11.023","volume":"150","author":"AR Menjoge","year":"2011","unstructured":"Menjoge AR, Rinderknecht AL, Navath RS, Faridnia M, Kim CJ, Romero R, Miller RK, Kannan RM (2011) Transfer of PAMAM dendrimers across human placenta: prospects of its use as drug carrier during pregnancy. J Control Release 150(3):326\u2013338","journal-title":"J Control Release"},{"issue":"5","key":"3897_CR106","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2174\/138920111795471010","volume":"12","author":"V Menezes","year":"2011","unstructured":"Menezes V, Malek A, Keelan JA (2011) Nanoparticulate drug delivery in pregnancy: placental passage and fetal exposure. Curr Pharm Biotechnol 12(5):731\u2013742","journal-title":"Curr Pharm Biotechnol"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-03897-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-020-03897-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-03897-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T18:42:49Z","timestamp":1667328169000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-020-03897-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,23]]},"references-count":106,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["3897"],"URL":"https:\/\/doi.org\/10.1007\/s10096-020-03897-6","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,23]]},"assertion":[{"value":"11 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}